Notas del episodio
Essential listening for biotech investors: Host Carmel Fisher interviews Dr. Vuong Trieu, Chairman and CEO of Oncotelic Therapeutics Inc. (OTCQB: OTLC), who has a proven track record of generating multi-billion dollar returns in biotech.
Investment Thesis: Dr. Trieu previously ...
Palabras clave
biosciencesotcmarketscarmel fisherOTCQBthe harvest podcastthe harvestbiotechbiopharmapharmaceuticalsharvest communicationscapital marketsbiotherapeuticsceo interviewsinvestment portfolioBiotechInvestingabraxanepatentscynviloqDr. Trieu$OTLCOncotelic Therapeuticsregulatory announcementsmilestoneslate-stage assetsportfolio diversification